SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-043739
Filing Date
2020-07-27
Accepted
2020-07-27 16:43:12
Documents
1
Period of Report
2020-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1519
  Complete submission text file 0001209191-20-043739.txt   3040
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
Protara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ROUTE 141 AND HENRY CLAY ROAD WILMINGTON DE 19880
Business Address
Flannelly Barry P (Reporting) CIK: 0001615842 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36694 | Film No.: 201050860